About us Contacts Drug interactions: 390 212
Drug search by name

Orap and Prozac Capsules

Determining the interaction of Orap and Prozac Capsules and the possibility of their joint administration.

Check result:
Orap <> Prozac Capsules
Relevance: 15.09.2023 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

Using FLUoxetine and pimozide is not recommended. Taking these drugs together can affect the rhythm of your heart. Call your doctor if you have symptoms of irregular heartbeat, chest tightness, blurred vision or nausea. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

CONTRAINDICATED: Coadministration with fluoxetine may significantly increase the plasma concentrations of pimozide. The proposed mechanism is fluoxetine inhibition of the metabolism of pimozide via CYP450 2D6 and 3A4. Although the interaction has not been formally studied with fluoxetine, data exist for paroxetine, a drug with similar CYP450 inhibition characteristics. In a controlled study of healthy volunteers, pretreatment with immediate-release paroxetine (titrated up to 60 mg/day) increased the peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) of pimozide (2 mg single oral dose) by an average of 62% and 151%, respectively, compared to administration of pimozide alone. The use of pimozide has been associated with dose-related prolongation of the QT interval, thus elevated plasma levels of the drug may potentiate the risk of ventricular arrhythmias such as ventricular tachycardia and torsade de pointes as well as cardiac arrest and sudden death. In addition, case reports suggest that concurrent administration of fluoxetine and pimozide may be associated with mental status changes and adverse cardiovascular effects. The mechanism of interaction has not been determined but may involve additive pharmacodynamic effects and/or fluoxetine inhibition of pimozide metabolism. In one case report, a young woman receiving pimozide for obsessive delusional thoughts became stuporous and complained of inability to think clearly following the addition of fluoxetine. She also had hypersalivation while receiving the combination. In another case, an elderly patient treated with pimozide developed severe bradycardia approximately one week after the addition of fluoxetine. Decreases in pulse also occurred during titration of the pimozide dose, but they were more significant with the combination of fluoxetine and pimozide. In other reports, use of selective serotonin reuptake inhibitors in combination with neuroleptics or other agents with antidopaminergic effect have resulted in increased extrapyramidal symptoms.

MANAGEMENT: Given the narrow therapeutic index of pimozide and its known ability to prolong the QT interval, concomitant use of pimozide and fluoxetine is considered contraindicated. Due to the long half-life of fluoxetine and its metabolite norfluoxetine, the risk of an interaction may exist for an extended period (up to several weeks) after discontinuation of fluoxetine.

References
  • Dsouza DC, Bennett A, Abidargham A, Krystal JH "Precipitation of a psychoneuromotor syndrome by fluoxetine in a haloperidol-treated schizophrenic patient." J Clin Psychopharmacol 14 (1994): 361-3
  • Nicholson SD "Extra pyramidal side effects associated with paroxetine." West Engl Med J 107 (1992): 90-1
  • Stein MH "Tardive dyskinesia in a patient taking haloperidol and fluoxetine." Am J Psychiatry 148 (1991): 683
  • Ozdemir V, Naranjo CA, Herrmann N, Reed K, Sellers EM, Kalow W "Paroxetine potentiates the central nervous system side effects of perphenazine: contribution of cytochrome P4502D6 inhibition in vivo." Clin Pharmacol Ther 62 (1997): 334-47
  • Ketai R "Interaction between fluoxetine and neuroleptics." Am J Psychiatry 150 (1993): 836-7
  • Tate JL "Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine." Am J Psychiatry 146 (1989): 399-400
  • "Product Information. Paxil (paroxetine)." GlaxoSmithKline, Research Triangle Park, NC.
  • Palop V, Jimenez MJ, Catalan C, MartinezMir I "Acute dystonia associated with fluvoxamine-metoclopramide." Ann Pharmacother 33 (1999): 382
  • Lock JD, Gwirtsman HE, Targ EF "Possible adverse drug interactions between fluoxetine and other psychotropics." J Clin Psychopharmacol 10 (1990): 383-4
  • "Product Information. Prozac (fluoxetine)." Dista Products Company, Indianapolis, IN.
  • Ahmed I, Dagincourt PG, Miller LG, Shader RI "Possible interaction between fluoxetine and pimozide causing sinus bradycardia." Can J Psychiatry 38 (1993): 62-3
  • Horrigan JP, Barnhill LJ "Paroxetine-pimozide drug interaction." J Am Acad Child Adolesc Psychiatry 33 (1994): 1060-1
  • Hansen-Grant S, Silk KR, Guthrie S "Fluoxetine-pimozide interaction." Am J Psychiatry 150 (1993): 1751-2
Orap

Generic Name: pimozide

Brand name: Orap

Synonyms: n.a.

Prozac Capsules

Generic Name: fluoxetine

Brand name: Prozac, Prozac Weekly, Sarafem, Rapiflux, Selfemra, PROzac Pulvules

Synonyms: Prozac

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.

Interaction with food and lifestyle
Disease interaction